Larynx carcinoma regulates tumor-associated macrophages through PLGF signaling

被引:0
作者
Xu Zhou
Ying Qi
机构
[1] Zhongshan Hospital,Otorhinolaryngology Department
[2] Fu Dan University,undefined
[3] 180 Fenglin Road,undefined
[4] State Key Laboratory of Molecular Engineering of Polymers (Fudan University),undefined
[5] 220 Handan Road,undefined
来源
Scientific Reports | / 5卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Cancer neovascularization plays an essential role in the metastasis of larynx carcinoma (LC). However, the underlying molecular mechanisms are not completely understood. Recently, we reported that placental growth factor (PLGF) regulates expression of matrix metalloproteinase 3 (MMP3) through ERK/MAPK signaling pathway in LC. Here, we show that MMP9 upregulated in LC and appeared to be mainly produced by M2 macrophages (tumor-associated macrophages (TAM)). In a transwell co-culture system, PLGF secreted by LC cells triggered macrophage polarization to a TAM subtype that releases MMP9. Moreover, MMP9 was found to be activated in the PLGF-polarized TAM via transforming growth factor β (TGFβ) receptor signaling activation. Furthermore, PLGF in LC cells induced macrophage polarization in vivo and significantly promoted the growth of LC. Thus, together with our previous work, our study highlights a pivotal role of cross-talk between TAM and LC in regulating the metastasis of LC.
引用
收藏
相关论文
共 84 条
[1]  
Mojica-Manosa P(2004)Larynx squamous cell carcinoma: concepts and future directions Surg. Oncol. Clin. N. Am. 13 99-112
[2]  
Reidy J(2001)Neoangiogenesis in squamous cell carcinoma of the larynx - biological and prognostic associations Pathol. Res. Pract. 197 1-5
[3]  
Wilson K(2010)Poor prognostic clinicopathologic features correlate with VEGF expression but not with PTEN expression in squamous cell carcinoma of the larynx Diagn. Pathol. 5 35-150
[4]  
Douglas W(2011)Serum perioperative profile of cytokines in patients with squamous cell carcinoma of the larynx Journal of otolaryngology - head & neck surgery = Le Journal d’oto-rhino-laryngologie et de chirurgie cervico-faciale 40 143-242
[5]  
Sion-Vardy N(2013)Missing the target: matrix metalloproteinase antitargets in inflammation and cancer Trends Pharmacol. Sci. 34 233-53
[6]  
Fliss DM(2002)The biological role and regulation of matrix metalloproteinases (MMP) in cancer Arkh. Patol. 64 47-211
[7]  
Prinsloo I(2002)RECKing MMP function: implications for cancer development Trends Cell Biol. 12 209-8541
[8]  
Shoham-Vardi I(2014)Targeting SMAD3 for inhibiting prostate cancer metastasis Tumour Biol. 35 8537-8658
[9]  
Benharroch D(2014)MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma Tumour Biol. 35 8653-6685
[10]  
Sullu Y(2014)Astrocyte elevated gene-1 activates MMP9 to increase invasiveness of colorectal cancer Tumour Biol. 35 6679-6678